These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 34181884)

  • 1. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
    Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
    Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset.
    Eysbouts YK; Ottevanger PB; Massuger LFAG; IntHout J; Short D; Harvey R; Kaur B; Sebire NJ; Sarwar N; Sweep FCGJ; Seckl MJ
    Ann Oncol; 2017 Aug; 28(8):1856-1861. PubMed ID: 28459944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
    Descargues P; Hajri T; Massardier J; Lotz JP; Devouassoux-Shisheboran M; Allias Montmayeur F; You B; Golfier F; Bolze PA
    Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?
    Braga A; Campos V; Filho JR; Lin LH; Sun SY; de Souza CB; da Silva RCAF; Leal EAS; Silveira E; Maestá I; Madi JM; Uberti EH; Viggiano M; Elias KM; Horowitz N; Berkowitz RS
    Gynecol Oncol; 2018 Feb; 148(2):239-246. PubMed ID: 29248195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and simplification of risk factors in FIGO 2000 scoring system for gestational trophoblastic neoplasia: a 19-year retrospective analysis.
    Weng Y; Liu Y; Benjoed C; Wu X; Tang S; Li X; Xie X; Lu W
    J Zhejiang Univ Sci B; 2022 Mar; 23(3):218-229. PubMed ID: 35261217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
    Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
    Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia.
    Strohl AE; Lurain JR
    Gynecol Oncol; 2016 May; 141(2):276-280. PubMed ID: 26896825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.
    Chapman-Davis E; Hoekstra AV; Rademaker AW; Schink JC; Lurain JR
    Gynecol Oncol; 2012 Jun; 125(3):572-5. PubMed ID: 22449733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of low-risk gestational trophoblastic neoplasia.
    Winter MC
    Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():67-80. PubMed ID: 33741258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study.
    Verri D; Pasciuto T; Epstein E; Fruscio R; Mascilini F; Moro F; Scambia G; Valentin L; Testa AC
    Int J Gynecol Cancer; 2019 Sep; 29(7):1216-1220. PubMed ID: 31248946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Maestá I; Growdon WB; Goldstein DP; Bernstein MR; Horowitz NS; Rudge MV; Berkowitz RS
    Gynecol Oncol; 2013 Aug; 130(2):312-6. PubMed ID: 23707672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group.
    Cioffi R; Bergamini A; Gadducci A; Cormio G; Giorgione V; Petrone M; Rabaiotti E; Pella F; Candiani M; Mangili G
    Int J Gynecol Cancer; 2018 Feb; 28(2):332-337. PubMed ID: 29324534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease.
    Braga A; Elias KM; Horowitz NS; Berkowitz RS
    Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():81-96. PubMed ID: 33622563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for methotrexate resistance in low-risk gestational trophoblastic neoplasia patients (FIGO score 0-4).
    Jin T; Zhou Z; Lin M; Yuan S; Xue Y; Yin T; Xu R; Chen B; Zhang J; Sun J; Li X; Hu Y; Chen L; Wang H
    Am J Cancer Res; 2024; 14(3):1353-1362. PubMed ID: 38590416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The influence of lung metastasis on prognosis of previously untreated gestational trophoblastic neoplasia patients].
    Lin JJ; Jiang F; Xiang Y; Wan XR; Feng FZ; Ren T; Yang JJ; Zhao J
    Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1139-1145. PubMed ID: 36319461
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-risk gestational trophoblastic neoplasia outcome after treatment with VMP regimen from 2005 to 2017.
    Zhu CC; Liu HY; Wei Y; Shen Z; Qian LL; Song WG; Wang J; Wu DB; Zhang XF; Zhou Y
    Taiwan J Obstet Gynecol; 2019 May; 58(3):332-337. PubMed ID: 31122520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The WHO score predicts treatment outcome in low risk gestational trophoblastic neoplasia patients treated with weekly intramuscular methotrexate.
    Gilani MM; Fariba B; Behtash N; Ghaemmaghami F; Moosavi AS; Rezayof E
    J Cancer Res Ther; 2013; 9(1):38-43. PubMed ID: 23575072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy is not needed when complete evacuation of gestational choriocarcinoma leads to hCG normalization.
    Bolze P; Schoenen S; Margaillan M; Braga A; Sauthier P; Elias K; Seckl M; Winter M; Coulter J; Lok C; Joneborg U; Undurraga Malinverno M; Hajri T; Massardier J; You B; Golfier F; Goffin F
    Eur J Surg Oncol; 2024 Mar; 50(3):108012. PubMed ID: 38350264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5.
    Li Y; Kong Y; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
    Oncologist; 2021 Dec; 26(12):e2209-e2216. PubMed ID: 34396643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom.
    Taylor F; Short D; Winter MC; Tidy J; Savage PM; Sarwar N; Hancock BW; Seckl MJ; Coleman RE
    Gynecol Oncol; 2015 Feb; 136(2):258-63. PubMed ID: 25542400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.